HIV/AIDS cure is needed to end the infection that is destroying the immune system of infected individuals. Human Immunodeficiency Virus a retrovirus that reproduces once and creates more viruses until the cell burst and infects new cells.
This is why it can spread easily and lead to stage IV and cause the death of the patient. But fortunately, in the last 40 years, HIV/AIDS has gone from an unknown deadly disease to a manageable condition that even allowed patients to live longer and enjoy healthy living again.
The treatments
Although the exact drug or HIV/AIDS cure has not been found yet, there are many types of treatments and medications available for patients these days. It should be noted that if HIV is left untreated, it can progress to become the fatal Acquired Immunodeficiency Syndrome (AIDS), so early treatment is always a must.
Currently, one of the available drugs given to the patients is the antiretroviral drugs. It is a medication that prevents the virus from reproducing in the body and lowers the number of HIV as well.
It was observed that the continuous taking of this ARV drug could also avert contagion. According to the World Health Organization, it can lessen the risk of transmission by 96%.
There is also the drug called the azidothymidine, and this was formulated in 1987. It can block the enzyme that plays a big role in HIV’s duplication. As of today, 55 drugs have been approved by the FDA as an HIV/AIDS cure.
The most recent breakthrough is the stem cell transplant that already cured two AIDS patients. However, more tests are needed because this was also tried on other patients, but so far, only two people have gotten rid of the virus completely.
Ending the HIV epidemic
Last year, President Donald Trump stated in his SOTU that one of his administration’s goals is to put an end to the HIV epidemic and promised that they will realize this in 10 years. As per HIV.gov, the POTUS mentioned this week that his administration has taken steps and started working private businesses and partners find HIV/AIDS cure and stop the infection.


FDA Weighs Safety Standards for Psychedelic Therapies
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
Trump Administration Bars U.S. Travelers From Congo Flights Amid Ebola Outbreak
GLP-1 Weight-Loss Drug Use Surges Among U.S. Children
Hanmi Pharm Soars 30% on $2.3 Billion Genentech Obesity Drug Deal
Novartis Shares Plunge After Muscle Drug Fails Phase III Trial
Alcohol is one of the most dangerous drugs, yet its presence is ubiquitous in social settings and celebrations
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
U.S. Issues Cuba Health Alert as Illnesses Rise
Trump Signs Order to Cut Routine Childhood Vaccines
Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race 



